Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04423991 · ClinicalTrials.gov registry record · NA
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning
A NA study of COVID-19 and Coronavirus, sponsored by Dascena.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
- 1
- Study location
NCT04423991 is a NA study of COVID-19 and Coronavirus that has completed, run by Dascena. The registered enrollment target is 290 participants, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04423991, a NA study of COVID-19 and Coronavirus, has completed, sponsored by Dascena.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to assess the performance of a machine learning algorithm which identifies patients for whom hydroxychloroquine treatment is associated with predicted survival.
Conditions Studied
Interventions
- DEVICE COViage
Study Locations (1)
California
- Dascena - Oakland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2020-03-10 |
| Est. Completion | 2020-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04423991
The ClinicalTrials.gov registry entry for NCT04423991 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Dascena, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which COViage is the first listed.
NCT04423991 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04423991 about?
NCT04423991 is a clinical study titled "Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning". The purpose of this study was to assess the performance of a machine learning algorithm which identifies patients for whom hydroxychloroquine treatment is associated with predicted survival.
What is the current status of trial NCT04423991?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2020-03-10. Estimated completion is 2020-06-04.
What conditions does trial NCT04423991 study?
This clinical trial studies the following conditions: COVID-19, Coronavirus, Mortality.
What interventions are being tested in trial NCT04423991?
The interventions under investigation include: COViage (DEVICE).
Who is sponsoring clinical trial NCT04423991?
This trial is sponsored by Dascena, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04423991 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.